These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8987417)

  • 1. Hepatitis B vaccination in the expanded programme of immunization.
    Mittal SK; Aggarwal V
    Trop Gastroenterol; 1996; 17(3):188-90. PubMed ID: 8987417
    [No Abstract]   [Full Text] [Related]  

  • 2. [Coverage of vaccination against hepatitis B in Poland in 2004].
    Magdzik W; Czarkowski MP
    Przegl Epidemiol; 2006; 60(2):185-92. PubMed ID: 16964668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vaccination against hepatitis B and epidemiological situation of this disease in European countries in the years 1990-2001].
    Magdzik W
    Przegl Epidemiol; 2006; 60(2):179-84. PubMed ID: 16964667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age at presentation for infant immunization in Nigeria: implications for hepatitis B immunization.
    Sadoh AE; Eregie CO
    Public Health; 2008 Dec; 122(12):1318-20. PubMed ID: 18706664
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis B vaccine.
    John TJ
    Indian Pediatr; 1995 May; 32(5):609-13. PubMed ID: 8613328
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunization and problems of newborns receiving hepatitis B vaccines in countryside].
    Li RC
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):241. PubMed ID: 12716529
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatitis-B vaccination.
    Phadke A; Kale A
    J Indian Med Assoc; 2004 May; 102(5):270. PubMed ID: 15636033
    [No Abstract]   [Full Text] [Related]  

  • 8. Global progress toward universal childhood hepatitis B vaccination, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(36):868-70. PubMed ID: 12970620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefits of early hepatitis B immunization programs for newborns and infants.
    Van Herck K; Van Damme P
    Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Outcomes of Polish hepatitis B vaccination program in comparison with European Union].
    Magdzik W
    Przegl Epidemiol; 2003; 57 Suppl 1():51-62. PubMed ID: 12921001
    [No Abstract]   [Full Text] [Related]  

  • 11. [Long-term efficacy of infant hepatitis B immunization program].
    Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Policy analysis of the use of Hepatitis B, Hemophilius influenzae type B, Steptococcus pneuomniae-conjugate and Rotavirus vaccines in the national immunization schedules.
    Puliyel JM
    Health Econ; 2004 Nov; 13(11):1147; author reply 1147-8. PubMed ID: 15547938
    [No Abstract]   [Full Text] [Related]  

  • 13. Integration of hepatitis B vaccination into national immunisation programmes. Alternative strategies must be considered before universal vaccination is adopted.
    Dunn J; Shukla R; Neal K
    BMJ; 1997 Jul; 315(7100):121-2. PubMed ID: 9240065
    [No Abstract]   [Full Text] [Related]  

  • 14. A success story: universal vaccination in Italy--what has to be done to eradicate residual acute hepatitis B?
    Gervais A; Longuet P; Leport C
    Clin Infect Dis; 2008 Mar; 46(6):876-7. PubMed ID: 18269331
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of the quebec school-based hepatitis B immunization program and potential benefit of the addition of an infant immunization program.
    Gîlca V; Duval B; Boulianne N; Dion R; De Serres G
    Pediatr Infect Dis J; 2006 Apr; 25(4):372-4. PubMed ID: 16567995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiological effect of hepatitis B immunization among newborn babies in Beijing].
    Gong XH; Liu LR; Jia L; Li YH; Xing YL; Wang QY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):201-2. PubMed ID: 12716513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
    Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
    Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B in Italy: where we are ten years after the introduction of mass vaccination.
    Mele A; Stroffolini T; Zanetti AR
    J Med Virol; 2002 Jul; 67(3):440-3. PubMed ID: 12116041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001.
    Van Damme P; Vorsters A
    J Med Virol; 2002 Jul; 67(3):433-9. PubMed ID: 12116040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.